Cannabis Conundrum

Recent research highlights that abstaining from cannabis for 28 days can lead to significant cognitive improvements and changes in brain activation among people with multiple sclerosis (MS). This study, presented by Omar Iqbal Khan, MD, emphasises the potential benefits of cannabis abstinence on the default mode network (DMN), which plays a crucial role in modulating

Adolescent polysubstance use, particularly among youth with early-onset cannabis use (CU), is a growing concern. This article delves into a study that examines the various polysubstance use profiles among adolescents with early-onset CU and how these profiles impact CU outcomes in early adulthood. Study Overview: The study aimed to determine whether outcomes in early adulthood

Cannabis use disorder (CUD) and cannabis use (CU) are significant conditions frequently co-occurring with attention-deficit hyperactivity disorder (ADHD). A recent genome-wide association study (GWAS) has shed light on the genetic overlap between ADHD and these cannabis-related conditions. This article delves into the study’s findings, highlighting the genetic loci associated with these disorders and their implications

The placebo effect is a fascinating phenomenon where a person experiences real changes in their health after receiving a treatment that has no therapeutic value. This effect is particularly notable in pain management. When a person believes they are receiving a pain-relieving treatment, their brain can release natural painkillers called endorphins. These chemicals interact with

The promotion and now clear marketing ‘spin’ on cannabinoids other than (but including) Delta 9 THC have been broadcast, largely unchecked for the last decade. Cannabidiol or CBD is just one of the 100 plus cannabinoids in this very complex and now completely unnatural plant that has been promoted as the ‘safe’ and health bringing